Home/Products /nintedanib-150mg-softgel

Ninasis Softgel: Your High-Value PCD Pharma Franchise for Respiratory Care

Name: Ninasis Softgel (Nintedanib 150mg) | PCD Pharma Franchise
Brand: Ninasis Softgel
Rating: 4.8 (150 reviews)

About Nintedanib 150mg: A Game-Changer in Idiopathic Pulmonary Fibrosis (IPF)

Tapping into the High-Value Super-Specialty Segment

Why Ninasis Softgel is a Profitable Niche Opportunity for Distributors

Partnering for Success with a Quality-Assured Product

Join Our Pharma Franchise for Unmatched Business Support

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Ninasis Softgel for PCD Pharma Franchise

Nintedanib 150mg Softgel for Idiopathic Pulmonary Fibrosis (IPF)

Ninasis Softgel wholesale supplier for pulmonology

PCD Pharma franchise for super-specialty respiratory medications

High-quality Nintedanib softgel for progressive lung fibrosis

Ninasis Softgel

Composition : Nintedanib 150mg Softgel

Dosage Form : Softgel

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Ninasis Softgel represents a significant advancement in the treatment of chronic and life-threatening respiratory diseases, particularly Idiopathic Pulmonary Fibrosis (IPF). Each softgel contains Nintedanib 150mg, a powerful tyrosine kinase inhibitor that specifically targets the growth factors responsible for the progressive scarring and fibrosis of lung tissue. As one of only two FDA-approved treatments for this condition, Nintedanib effectively slows the decline in lung function, improves patient quality of life, and is considered the gold standard of care by pulmonologists. The convenient softgel formulation enhances bioavailability and patient adherence, making it a preferred choice for long-term management of this debilitating disease.

The market for specialty respiratory and anti-fibrotic medications is a high-growth, high-value segment within the Indian pharmaceutical industry. While IPF is a rare disease, the chronic nature of the condition and the high cost per therapy lead to a consistent and substantial revenue stream for distributors. The growing number of diagnoses and increasing awareness among healthcare professionals create a significant and untapped market opportunity. Investing in a specialized product like Ninasis Softgel positions you to capture this profitable niche, serving a critical healthcare need with a product that is both clinically essential and financially rewarding.

We are dedicated to empowering our franchise partners with all the tools necessary for success in this professional market. Our product is manufactured in a WHO-GMP certified facility, ensuring impeccable quality, efficacy, and safety, which is paramount for a drug of this nature. We provide a complete promotional and marketing kit, including detailed product literature and clinical data, to support your engagement with specialized healthcare professionals. Our robust supply chain guarantees timely delivery and continuous stock availability. Partner with us to establish a reputable and successful business as a key supplier of this critical and top-quality medicine in the super-specialty respiratory market.

About the Product

Mild side effects may include nausea, headache, or gastrointestinal discomfort. Rarely, allergic reactions may occur.

Nuroslide OD Capsule is indicated for peripheral neuropathy, diabetic neuropathy, and nerve-related conditions. It supports nerve repair, improves energy metabolism, and reduces oxidative stress.

Use as directed by your healthcare provider. Do not exceed the recommended dosage. Inform your doctor of any pre-existing medical conditions or ongoing medications.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.